These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15969626)

  • 1. CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donors.
    Vela-Ojeda J; Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Stem Cells Dev; 2005 Jun; 14(3):310-6. PubMed ID: 15969626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Ann Hematol; 2006 May; 85(5):308-14. PubMed ID: 16525786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF.
    Gazitt Y; Akay C; Thomas C
    Stem Cells Dev; 2006 Apr; 15(2):269-77. PubMed ID: 16646673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study.
    Mueller MM; Bialleck H; Bomke B; Brauninger S; Varga C; Seidl C; Seifried E; Tonn T; Bonig H
    Vox Sang; 2013 Jan; 104(1):46-54. PubMed ID: 22827736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of mobilization with medium dose of rhG-CSF on the immunocyte component of peripheral blood in donors].
    Huang WR; Da WM; Deng XL; Gao CJ; Han XP; Wu XX; Li HH; Zhu HY; Jin HJ; Jing Y; Wang SH; Bo J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):852-6. PubMed ID: 16277857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.
    Tayebi H; Kuttler F; Saas P; Lienard A; Petracca B; Lapierre V; Ferrand C; Fest T; Cahn J; Blaise D; Kuentz M; Hervé P; Tiberghien P; Robinet E
    Exp Hematol; 2001 Apr; 29(4):458-70. PubMed ID: 11301186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
    Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
    Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The differences between recombinant human granulocyte colony-stimulating factor-primed and non-primed peripheral blood stem cell harvests].
    Liang X; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):566-8. PubMed ID: 17959081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.
    Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø
    Front Immunol; 2018; 9():845. PubMed ID: 29770133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors.
    Rodríguez-Cortés O; Vela-Ojeda J; López-Santiago R; Montiel-Cervantes L; Reyes-Maldonado E; Estrada-García I; Moreno-Lafont MC
    J Clin Apher; 2010; 25(4):181-7. PubMed ID: 20818712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
    Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
    Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
    Morris ES; MacDonald KP; Rowe V; Banovic T; Kuns RD; Don AL; Bofinger HM; Burman AC; Olver SD; Kienzle N; Porcelli SA; Pellicci DG; Godfrey DI; Smyth MJ; Hill GR
    J Clin Invest; 2005 Nov; 115(11):3093-103. PubMed ID: 16224535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
    Huang XJ; Chang YJ; Zhao XY
    Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
    Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
    Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.
    Noël G; Bruniquel D; DeGuibert S; Birebent B; Grosset JM; Bernard M; Dauriac C; Lamy-de-la-Chapelle T; Semana G; Brinster C
    Hum Immunol; 2008 Jun; 69(6):329-37. PubMed ID: 18571003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation.
    Hock BD; Haring LF; Ebbett AM; Patton WN; McKenzie JL
    Bone Marrow Transplant; 2002 Dec; 30(11):733-40. PubMed ID: 12439695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of dendritic cells and NK cells in non-Hodgkin's lymphoma patients mobilized with different growth factors.
    Gazitt Y; Shaughnessy P; Devore P
    J Hematother Stem Cell Res; 2001 Feb; 10(1):177-86. PubMed ID: 11276371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.